Gene · 5345
Papers4,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival. | Front Genet | 2022 | 36338974 | PubTator, text mining | PubMed |
| Serpin-loaded extracellular vesicles promote tissue repair in a mouse model of impaired wound healing. | J Nanobiotechnology | 2022 | 36335351 | PubTator, text mining | PubMed |
| High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron. | BMC Infect Dis | 2022 | 36335289 | PubTator, text mining | PubMed |
| Identification of hub ferroptosis-related genes and immune infiltration in lupus nephritis using bioinformatics. | Sci Rep | 2022 | 36335193 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Exploring novel independent prognostic biomarkers for hepatocellular carcinoma based on TCGA and GEO databases. | Medicine (Baltimore) | 2022 | 36316888 | PubTator, text mining | PubMed |
| Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patients. | Front Oncol | 2022 | 36313660 | PubTator, text mining | PubMed |
| The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19. | Front Cardiovasc Med | 2022 | 36304538 | PubTator, text mining | PubMed |
| Historical Perspectives and Evolution of Menstrual Terminology. | Front Reprod Health | 2022 | 36303670 | PubTator, text mining | PubMed |
| The Challenge of Long COVID-19 Management: From Disease Molecular Hallmarks to the Proposal of Exercise as Therapy. | Int J Mol Sci | 2022 | 36293160 | PubTator, text mining | PubMed |
| Immunological Aspects of Chronic Rhinosinusitis. | Diagnostics (Basel) | 2022 | 36292050 | PubTator, text mining | PubMed |
| Engineering Spatiotemporal Control in Vascularized Tissues. | Bioengineering (Basel) | 2022 | 36290523 | PubTator, text mining | PubMed |
| A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity. | PLoS One | 2022 | 36260611 | PubTator, text mining | PubMed |
| Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma? | BMC Cancer | 2022 | 36258189 | PubTator, text mining | PubMed |
| Antithrombin activity levels for predicting long-term outcomes in the early phase of isolated traumatic brain injury. | Front Immunol | 2022 | 36248813 | PubTator, text mining | PubMed |
| The immunomodulatory functions of chromogranin A-derived peptide pancreastatin. | Peptides | 2022 | 36244579 | PubTator, text mining | PubMed |
Tranexamic acid dose-response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study. | Br J Anaesth | 2022 | 36243576 | PubTator, text mining | PubMed |
| Beyond COVID-19 and SARS-CoV-2, cardiovascular outcomes of "long covid" from a pathological perspective - a look back and road ahead. | Pathol Res Pract | 2022 | 36242969 | PubTator, text mining | PubMed |
| CRISPR/Cas systems usher in a new era of disease treatment and diagnosis. | Mol Biomed | 2022 | 36239875 | PubTator, text mining | PubMed |
| Understanding the extracellular vesicle surface for clinical molecular biology. | J Extracell Vesicles | 2022 | 36239734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5345/papers?page=29